Lead clinical-stage program, OLN324, is a higher potency VEGF/Ang2 bispecific antibody in a fully-recruited head-to-head study versus faricimab in wet AMD and DME, with topline data expected Q1 2026 ...
Cybersecurity researchers have flagged a "coordinated malware campaign" on the JetBrains Marketplace that has published no less than 15 malicious plugins capable of exfiltrating artificial ...
Pacific Biosciences of California, Inc. (NASDAQ:PACB) is one of the 8 Best Genomics Stocks to Buy According to Analysts. On May 26, Pacific Biosciences of California, Inc. (NASDAQ:PACB) began global ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
June 9 (Reuters) - Privately held Element Biosciences said on Tuesday it had raised funds, including $175 million from longtime investor Samsung Electronics (005930.KS), opens new tab, to expand ...
Test time has arrived: the first person has been treated in a highly anticipated gene-therapy trial that aims to coax aged cells to take on a younger identity. The clinical trial is testing an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results